Sonja Su Pennington LCSW

Recommended Articles

• What is Angina?

  Angina refers to chest discomfort, tightness, or pain that occurs due to a reduction in blood supply to the muscles of the heart. People commonly confuse this chest pain and discomfort with indigestion. Angina can cause an individual's chest to feel heavy, achey, tight, in addition to a burning...

• The Robotic Device to Improve Balance and Gait in Parkinson’s Patients

  Parkinson’s disease is a neurodegenerative disorder that severely incapacitates the patient, rendering him or her unable to perform certain tasks — especially in its more advanced stages. Fortunately, when compared to other neurodegenerative disorders, such as Alzheimer’s, Parkinson’s is...

• A333 Pill

  A333 PillIt is a white and capsule-shaped pill. It has been identified as acetaminophen/oxycodone 325mg/10 mg. It is used for the treatment of chronic pain. This drug is supplied by Actavis Elizabeth.It is a member of the drug class narcotic analgesic combination. During pregnancy, its risk cannot...

• What Are the Side Effects of Cholecystectomy?

  Cholecystectomy is a common surgical operation currently performed for the treatment of gallbladder problems. The operation is basically a surgery done to remove the gallbladder. The removal of the gallbladder can be done in two different methods.Methods Used in a CholecystectomyOne of the methods...

• Teenagers with Type 1 Diabetes May Face Body Image Problems

  Diabetes is a disease that affects an estimated one million people or more in the United states alone. It’s a disease that’s characterized by the body’s inability to make, process or use insulin sufficiently. Diabetes can affect just about anyone but there are risk factors that make some more...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...